BD BBL Trypticase Soy Agar Recall: Inhibited Gram Negative Growth Risk
Becton Dickinson recalls BD BBL Trypticase Soy Agar with 5% Sheep Blood (Lot 8221508) due to inhibited growth of Gram negative bacteria. Affected users should contact for remedy.
Lower-risk recall
a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms.
Contact the company
What happened, in plain English
Becton Dickinson is recalling a specific lot of BD BBL Trypticase Soy Agar with 5% Sheep Blood because it may not grow certain bacteria properly. This could affect lab results if used in testing. The recall is for a single lot, not all products. Read more at govinfonow.com/recall/69566-bd-bbl-trypticase-soy-agar-recall-inhibited-gram-negative-growth.
Source Summary by GovInfoNow · govinfonow.com/recall/69566-bd-bbl-trypticase-soy-agar-recall-inhibited-gram-negative-growth · Updated August 20, 2026 · FDA enforcement record: FDA #Z-0528-2019
Cite this page
“BD BBL Trypticase Soy Agar Recall: Inhibited Gram Negative Growth Risk.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69566-bd-bbl-trypticase-soy-agar-recall-inhibited-gram-negative-growth. Based on FDA recall #Z-0528-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0528-2019%22&limit=1).
Why it’s dangerous
The product was made incorrectly in one lot, which means it might not grow Gram negative bacteria as it should. This could lead to inaccurate lab results if used in testing. However, the issue only affects one specific lot, not the entire product line.
Who’s affected
Lab users who purchased the specific lot (8221508) from the manufacturer. Those using this agar for bacterial culture testing are most at risk.
How to tell if you have this one
Check for the lot number 8221508 on the packaging. The product is labeled as BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261. It expired on November 30, 2018.
- Brand
Becton Dickinson- Product
BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential)- Category
Medical device
What to do — step by step
Check Product Details
Look for the lot number 8221508 on the packaging to confirm if your product is affected.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 25 states.
FDA distribution: “US Nationwide distribution in the states of AL, AR, AZ, CA, CT, FL, GA, HI, MA, MD, MI, MN, NC, NH, NJ, NY, OH, OK, PA, RI, TX, VA, VT, WA, WV” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Hawaii, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Texas, Vermont, Virginia, Washington, West Virginia.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0528-2019 (October 22, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0528-2019 to see it in context.
- Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.